Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England

J Med Microbiol. 2020 Jul;69(7):1034-1036. doi: 10.1099/jmm.0.001215.

Authors

Claire Jenkins¹, Lisa Byrne¹, Bhavita Vishram¹, Clare Sawyer^{2

3}, Sooria Balasegaram³, Laura Ahyow⁴, Sally Johnson⁵

Affiliations

¹ National Infection Service, Public Health England, London NW9 5HT, UK.
² Public Health Wales, Cardiff CF10 4BZ, UK.
³ Field Services - South East and London, Public Health England, London SE1 6LH, UK.
⁴ East Midlands Health Protection Team, Public Health England, Nottingham NG2 4LA, UK.
⁵ Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle NE1 4LP, UK.

No abstract available

Keywords: PCR; Shiga toxin-producing Escherichia coli; faecal specimens; public health; treatment.

MeSH terms

Disease Notification
Early Diagnosis
England / epidemiology
Epidemiological Monitoring
Hemolytic-Uremic Syndrome / diagnosis*
Hemolytic-Uremic Syndrome / epidemiology
Hemolytic-Uremic Syndrome / therapy*
Humans
Practice Guidelines as Topic
Shiga-Toxigenic Escherichia coli / isolation & purification*